The non-compliance in the parameter “zinc sulfate monohydrate content” indicated by OMCL may affect product quality and safety of use, and therefore a risk to human health cannot be excluded. Potential effects: lack of treatment efficacy, possible disease complications, skin reactions.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use ointment from batch E0153, check the batch number on the package and return the product to a pharmacy or consult a doctor/pharmacist to determine further treatment.
The Chief Pharmaceutical Inspector withdrew Hemkortin-HC batch E0153 from the market nationwide, prohibited its placing on the market, and granted the decision immediate enforceability; previously, di...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related